J. Innes

发表

Reflex pharyngeal dilator muscle activation by stimuli of negative airway pressure in awake man.

A. Guz, R. Horner, J. Innes, 1993, Sleep.

Systemic haemodynamic changes in patients with cystic fibrosis with and without chronic liver disease.

S. Williams, A. Guz, D. Geddes, 1996, Journal of hepatology.

Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI.

G. Crompton, J. Innes, J. Lenney, 2000, Respiratory medicine.

Ultrasound evaluation of blunt abdominal trauma: program implementation, initial experience, and learning curve.

R. Falcone, J. Innes, S. Wanamaker, 1997, Journal of Trauma.

Expired hydrogen peroxide in breath condensate of cystic fibrosis patients.

L. Ho, J. Innes, J. Faccenda, 1999, The European respiratory journal.

Afferent pathway(s) for pharyngeal dilator reflex to negative pressure in man: a study using upper airway anaesthesia.

A. Guz, R. Horner, J. Innes, 1991, The Journal of physiology.

Sputum trace metals are biomarkers of inflammatory and suppurative lung disease.

D. Porteous, R. Gray, J. Innes, 2010, Chest.

Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis

T. Welte, P. Burgel, C. Castellani, 2015, European Respiratory Journal.

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.

D. Porteous, J. Davies, M. Hasegawa, 2012, American journal of respiratory and critical care medicine.

P95 Assessment of F/HN-pseudotyped Lentivirus as a Clinically Relevant Vector For Lung Gene Therapy

J. Davies, M. Hasegawa, D. Gill, 2012, Thorax.

Recombinant DNase in cystic fibrosis: a protocol for targeted introduction through n-of-1 trials. Scottish Cystic Fibrosis Group.

J. Calvert, J. Paton, F. Böllert, 1999, The European respiratory journal.

Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.

J. Innes, A. Greening, H. C. Rodgers, 1998, The European respiratory journal.

Problems of air travel for patients with lung disease: clinical criteria and regulations

J. Innes, A. Robson, 2006, Breathe.

Cardiopulmonary response to dynamic exercise after heart and combined heart-lung transplantation.

M. Yacoub, A. Guz, N. Banner, 1989, British heart journal.

Ventilatory and circulatory responses at the onset of exercise in man following heart or heart‐lung transplantation.

M. Yacoub, K. Murphy, A. Guz, 1988, The Journal of physiology.

Lung clearance index in CF: a sensitive marker of lung disease severity

J. Davies, E. Alton, S. Cunningham, 2007, Thorax.

Preparation for a fi rst-inman lentivirus trial in patients with cystic fi brosis

A. Doherty, T. Maher, A. Rodriguez-Martinez, 2016 .

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

A. Doherty, T. Maher, A. Rodriguez-Martinez, 2016, Thorax.

Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide

L. Ho, J. Innes, A. Greening, 1998, Thorax.

Double-blind evaluation of mazindol in refractory obesity.

J. Innes, J. Munro, R. Smith, 1975, British medical journal.

Fenfluramine, vitamin C and weight loss.

J. Innes, J. Munro, C. W. Wilson, 1978, International journal of obesity.

Plasma fenfluramine levels, weight loss, and side effects.

J. Innes, J. Munro, M. Watson, 1977, British medical journal.

Effect of positive and negative step changes in intrathoracic pressure on left ventricular function in conscious man.

A. Guz, J. Innes, S. De Cort, 1993, The Journal of physiology.

Atopy influences exhaled nitric oxide levels in adult asthmatics.

L. Ho, J. Innes, A. Greening, 2000, Chest.

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung

D. Porteous, D. Shaw, R. Scheule, 2011, Gene Therapy.

Long-term Follow-up of Therapeutic Starvation

I. Campbell, J. Innes, C. J. Campbell, 1974, British medical journal.

Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease

S. Cunningham, N. Bell, J. Innes, 2008, Thorax.

Airways in cystic fibrosis are acidified: detection by exhaled breath condensate

J. Innes, A. Greening, G. MacGregor, 2002, Thorax.

Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis.

L. Ho, J. Innes, A. Greening, 1998, The European respiratory journal.

Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations

J. Innes, A. Greening, S. Tate, 2004, Thorax.

Abdominal pain in diabetic metabolic decompensation. Clinical significance.

I. Campbell, L. J. Duncan, J. Innes, 1975, JAMA.

The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre.

L. Ho, J. Innes, A. Greening, 2000, The European respiratory journal.

Non‐islet cell tumour‐associated hypoglycaemia: 111In‐octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids

J. McKnight, P. Perros, J. Simpson, 1996, Clinical endocrinology.

Inspiratory coactivation of the genioglossus enlarges retroglossal space in laryngectomized humans.

K. Murphy, A. Guz, B. Wuyam, 1996, Journal of applied physiology.

Laboratory assessment of fitness to fly in patients with lung disease: a practical approach.

J. Innes, A. Robson, T. Hartung, 2000, The European respiratory journal.

Sputum and serum calprotectin are useful biomarkers during CF exacerbation.

D. Porteous, R. Gray, J. Innes, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

UK cystic fibrosis gene therapy consortium tracking study: Exhaled breath condensate pH increases with treatment of an infective exacerbation

D. Porteous, D. Geddes, R. Gray, 2007 .

Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis.

D. Porteous, R. Gray, J. Innes, 2015, American journal of respiratory and critical care medicine.

Preparation for a ﬁ rst-in-man lentivirus trial in patients with cystic ﬁ brosis

A. Doherty, T. Maher, A. Rodriguez-Martinez, 2016 .

A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.

D. Porteous, J. Davies, S. Hyde, 2015, American journal of respiratory and critical care medicine.

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung

D. Porteous, R. Scheule, J. Davies, 2013, Gene Therapy.

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.

D. Porteous, D. Shaw, R. Scheule, 2013, Biomaterials.

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis

D. Porteous, G. Murray, Seng H. Cheng, 2013, Thorax.

Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis

D. Porteous, S. Cunningham, P. Gustafsson, 2007, Thorax.

The effects of exercise and subject age on pulsed Doppler measurements of left ventricular ejection in normal man.

K. Murphy, A. Guz, J. Innes, 1988, Quarterly journal of experimental physiology.

Polymyalgia arteritica: a clinical review

J. Douglas, J. Innes, J. Munro, 1979, European journal of clinical investigation.

Cardiac output, oxygen consumption and arteriovenous oxygen difference following a sudden rise in exercise level in humans.

A. Guz, T. Barstow, J. Innes, 1991, The Journal of physiology.

Self-reactive CFTR T cells in humans: implications for gene therapy.

D. Porteous, James M. Wilson, J. Davies, 2013, Human gene therapy. Clinical development.

Hypersensitivity pneumonitis associated with leflunomide therapy.

C. Turnbull, J. Innes, N. Martin, 2007, The Journal of rheumatology.

Exhaled breath temperature in airways disease

J. Innes, J. McCafferty, J. McCafferty, 2003, European Respiratory Journal.

Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis.

D. Porteous, A. Carothers, J. Dorin, 1997, The European respiratory journal.

Central and reflex neural control of genioglossus in subjects who underwent laryngectomy.

A. Guz, M. Morrell, I. Kobayashi, 1995, Journal of applied physiology.

Towards gene therapy for cystic fibrosis: a clinical progress report

D. Gill, E. Alton, J. Innes, 1998, Gene Therapy.

Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma.

G. Crompton, S. Matusiewicz, J. Innes, 2008, Respiratory medicine.

Breathing patterns in recipients of heart-lung transplants.

B. Griffith, M. Yacoub, S. Shea, 1989, The New England journal of medicine.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Steve Cunningham, Joseph Jacob, Sarah Sheard, 2015 .

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis

A. Doherty, T. Maher, A. Rodriguez-Martinez, 2016, Thorax.

The early circulatory and ventilatory response to voluntary and electrically induced exercise in man.

K. Murphy, L. Adams, A. Guz, 1987, The Journal of physiology.

Evidence for reflex upper airway dilator muscle activation by sudden negative airway pressure in man.

K. Murphy, A. Guz, R. Horner, 1991, The Journal of physiology.

Genetic medicines for CF: Hype versus reality

J. Davies, S. Hyde, D. Gill, 2016, Pediatric pulmonology.

Serum Protein Analysis and Bone Marrow Cytology in Patients with an Extreme Elevation of the Erythrocyte Sedimentation Rate

J. Innes, J. Munro, M. J. Ford, 1978, Scottish medical journal.

Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid.

D. Porteous, R. Gray, A. Bush, 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Sputum proteomics in inflammatory and suppurative respiratory diseases.

D. Porteous, R. Gray, M. Dewar, 2008, American journal of respiratory and critical care medicine.

Tuberculous otitis media—A reminder

S. Glover, J. Innes, R. Tranter, 1981, The Journal of Laryngology & Otology.

Within‐breath modulation of left ventricular function during normal breathing and positive‐pressure ventilation in man.

A. Guz, W. Kox, J. Innes, 1993, The Journal of physiology.

Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation

D. Hansell, D. Porteous, D. Ashby, 2013, Thorax.

The significance of gross elevations of the erythrocyte sedimentation rate in a general medical unit

J. Innes, J. Munro, N. Allan, 1979, European journal of clinical investigation.

Renal mobility in women attending a pyelonephritis clinic and in controls.

R. Prescott, A. Geddes, J. Innes, 1978, British journal of urology.

Biomarkers for cystic fibrosis lung disease

D. Porteous, R. Gray, A. Bush, 2016 .

Hyperpnoea during and immediately after exercise in man: evidence of motor cortical involvement.

J. D. Watson, Richard S. J. Frackowiak, K. Murphy, 1995, The Journal of physiology.

Central command influences cardiorespiratory response to dynamic exercise in humans with unilateral weakness.

A. Guz, J. Innes, P. Evans, 1992, The Journal of physiology.

Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma

J. Innes, A. Greening, D. Noble, 2007, European Respiratory Journal.

Cardiopulmonary response todynamicexercise after heart andcombinedheart-lung transplantation

M. Yacoub, A. Guz, N. Banner, 2017 .

Forced Expiratory Volume in One Second Predicts Length of Stay and In-Hospital Mortality in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Study

S. Wild, W. MacNee, D. Newby, 2013, PloS one.

Respiration during recovery from exercise: effects of trapping and release of femoral blood flow.

B. Whipp, K. Wasserman, J. Innes, 1989, Journal of applied physiology.

Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAP.

D. Porteous, G. Mclachlan, E. Alton, 1996, Gene therapy.

Short term variability of single breath carbon monoxide transfer factor

J. Innes, A. Robson, 2001, Thorax.

The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans.

S A Shea, A. Guz, M. Morrell, 1994, The Journal of physiology.

Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis

G. Mclachlan, U. Michaelis, K. Naujoks, 1997, Gene Therapy.

Emergency pre-hospital management of patients admitted with acute asthma

G. Crompton, S. Matusiewicz, J. Innes, 2000, Thorax.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

P. Reix, L. Kent, J. Bradley, 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Measure and interpretation of CF gene therapy trial results.

D. Porteous, D. Gill, J. Innes, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

UKCF gene therapy consortium tracking study: Lung clearance index improves with treatment of an infective exacerbation

D. Porteous, D. Geddes, R. Gray, 2007 .

A qualitative study of cystic fibrosis (CF) patients' expectations of gene therapy

P. Morris, M. Dewar, J. Innes, 2010 .

Moving from CFC Aerosol to HFA Aerosol or Dry Powder Inhalers: What Do Patients Think?

H. Allbutt, G. Crompton, M. Dewar, 2002, Respiration.

Respiratory modulation of left ventricular stroke volume in man measured using pulsed Doppler ultrasound.

K. Murphy, A. Guz, J. Innes, 1987, The Journal of physiology.

T4 Safety and expression of a single dose of lipid-mediated CFTR gene therapy to the upper and lower airways of patients with Cystic Fibrosis

R. Scheule, S. Hyde, D. Gill, 2011, Thorax.

Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis

S. Cunningham, N. Bell, P. Gustafsson, 2008, Respiratory Physiology & Neurobiology.

Role of muscle perfusion and baroreception in the hyperpnea following muscle contraction in dog.

B. Whipp, K. Wasserman, J. Innes, 1993, Respiration physiology.

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator ( CFTR) gene therapy in patients with cystic fibrosis

A. Nicholson, D. Hansell, A. Maclean, 2016 .

Validation of beat by beat pulsed Doppler measurements of ascending aortic blood velocity in man.

K. Murphy, A. Guz, M. Noble, 1987, Cardiovascular research.

Expired hydrogen peroxide in breath condensate of cystic fibrosis patients.

L. Ho, J. Innes, J. Faccenda, 1999, European Respiratory Journal.

Development of sputum calprotectin as a biomarker of cystic fibrosis lung disease activity: Evidence from cross sectional and longitudinal studies

D. Porteous, R. Gray, J. Innes, 2006 .

Pneumothorax in cystic fibrosis: prevalence and outcomes in Scotland.

A. Macduff, J. Innes, J. Tweedie, 2010, Journal of Cystic Fibrosis.

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

A. Nicholson, D. Hansell, A. Maclean, 2015, The Lancet. Respiratory medicine.

Safety and adverse events

A. Nicholson, D. Hansell, A. Maclean, 2016 .